Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.
Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR. Mol Cancer Ther. 2017 08; 16(8):1470-1486.
View in:
PubMed
subject areas
Animals
Animals
Cell Cycle Checkpoints
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Line, Tumor
Cell Movement
Cell Movement
Cell Proliferation
Cell Proliferation
Drug Delivery Systems
Drug Delivery Systems
ELAV-Like Protein 1
ELAV-Like Protein 1
Female
Female
G1 Phase
G1 Phase
Gene Knockdown Techniques
Gene Knockdown Techniques
Gene Silencing
Gene Silencing
Humans
Humans
Lung Neoplasms
Lung Neoplasms
Mice, Nude
Mice, Nude
Nanoparticles
Nanoparticles
Neoplasm Invasiveness
Neoplasm Invasiveness
Oncogenes
Oncogenes
Receptors, Transferrin
Receptors, Transferrin
RNA, Small Interfering
RNA, Small Interfering
Static Electricity
Static Electricity
Tissue Distribution
Tissue Distribution
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Anupama Munshi
Yan Daniel Zhao
Rajagopal Ramesh